Grufity logoGrufity logo
Stocks
Funds
Screener
Sectors
Watchlists

TWST - Twist Bioscience Corp Stock Price, Fair Value and News

$39.19+1.48 (+3.92%)
Market Closed
Max Portfolio Pct.
Check
Valuation
Check

Stock Quality:

GPSDBMFI
Max Portfolio Pct.
Check
Valuation
Check
GPSDBMFI

TWST Price Action

Last 7 days

-2.3%

Last 30 days

2.6%

Last 90 days

-25.2%

Trailing 12 Months

22.4%

TWST Stock Price

TWST RSI Chart

AugSepOctNovDec2025FebMarAprMay102030405060708090

TWST Valuation

Market Cap

2.3B

Price/Earnings (Trailing)

-11.85

Price/Sales (Trailing)

7.08

EV/EBITDA

-12.66

Price/Free Cashflow

-34.18

TWST Price/Sales (Trailing)

202220232024202501020304050

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

TWST Fundamentals

TWST Revenue

Revenue (TTM)

330.2M

Rev. Growth (Yr)

24.08%

Rev. Growth (Qtr)

4.73%

2018202020222024050M100M150M200M250M300M350M

TWST Earnings

Earnings (TTM)

-197.3M

Earnings Growth (Yr)

26.54%

Earnings Growth (Qtr)

8.83%

2018202020222024-200M-150M-100M-50M

TWST Profitability

Operating Margin

44.59%

EBT Margin

-59.59%

Return on Equity

-43.28%

Return on Assets

-32.42%

Free Cashflow Yield

-2.93%

TWST Investor Care

Shares Dilution (1Y)

3.17%

Diluted EPS (TTM)

-3.38

Revenue Breakdown

As of: Dec 31, 2024
Ngs Tools
ProductValuePercent
GeographyValuePercent
TotalValuePercent

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
2024277.5M295.2M313.0M330.2M
2023227.8M235.5M245.1M262.4M
2022163.1M184.2M203.6M215.8M
2021113.0M126.8M132.3M146.2M
202065.8M73.4M90.1M101.1M
201940.0M47.1M54.4M60.1M
201818.1M21.8M25.4M32.6M
20170010.8M14.4M
Get all data in R, Python etc through our Historical Stock Data APIs

About Twist Bioscience Corp

Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. The company's DNA synthesis platform enables the manufacturing of synthetic DNA by writing DNA on a silicon chip. It offers synthetic DNA-based products, including synthetic genes, tools for sample preparation, antibody libraries for drug discovery and development, and DNA as a digital data storage medium. The company has collaboration agreements with Victorian Clinical Genetic Services; Vivlion GmbH.; Kyowa Kirin Pharmaceutical Research, Inc.; deepCDR Biologics AG; and Centogene N.V to develop advanced sequencing tools. It also has a research collaboration with Boehringer Ingelheim International GmbH to use proprietary antibody libraries to discover therapeutic antibodies against multiple targets. The company was incorporated in 2013 and is headquartered in South San Francisco, California.
 CEO
 WEBSITEtwistbioscience.com
 SECTORHealthcare
 INDUSTRYDiagnostics & Research
 EMPLOYEES989

Twist Bioscience Corp Frequently Asked Questions

What is the ticker symbol for Twist Bioscience Corp? What does TWST stand for in stocks?

TWST is the stock ticker symbol of Twist Bioscience Corp. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Twist Bioscience Corp (TWST)?

As of Fri May 02 2025, market cap of Twist Bioscience Corp is 2.34 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of TWST stock?

You can check TWST's fair value in chart for subscribers.

Is Twist Bioscience Corp a good stock to buy?

The fair value guage provides a quick view whether TWST is over valued or under valued. Whether Twist Bioscience Corp is cheap or expensive depends on the assumptions which impact Twist Bioscience Corp's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for TWST.

What is Twist Bioscience Corp's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Fri May 02 2025, TWST's PE ratio (Price to Earnings) is -11.85 and Price to Sales (PS) ratio is 7.08. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. TWST PE ratio will change depending on the future growth rate expectations of investors.